Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q2 2023 · 10-Q
Revenue$6.24M$6.24M−35.2% vs Q2 2022 Net Income-$1.34M-$1.34MN/M vs Q2 2022 EPS Diluted-$1.74-$1.74N/M vs Q2 2022 Gross Profit$4,015,508−37.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,733,620N/M Free Cash Flowderived-$1,631,230N/M Margins · derivedGross margin64.4%−2.6 pt vs Q2 2022
Operating margin-22.4%+29.6 pt vs Q2 2022
Net margin-21.4%+26.9 pt vs Q2 2022
ended Mar 31, 2023 · filed May 15, 2023 · 45 d after period end